Jul 25, 2023
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.21 to $0.01.
The split itself did not change the total investment value.
OncoCyte Corporation (OCX) trades on the NASDAQ Global Market in the Biotechnology industry.
OncoCyte Corporation company overviewThe latest split shown was on July 25, 2023. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records one reverse split, on July 25, 2023.